The estimated Net Worth of Peter Grunebaum is at least $2.47 Million dollars as of 17 March 2014. Peter Grunebaum owns over 15,000 units of PPD Inc stock worth over $877,044 and over the last 21 years Peter sold PPD stock worth over $1,595,265.
Peter has made over 50 trades of the PPD Inc stock since 2003, according to the Form 4 filled with the SEC. Most recently Peter exercised 15,000 units of PPD stock worth $282,000 on 17 March 2014.
The largest trade Peter's ever made was exercising 15,000 units of PPD Inc stock on 17 March 2014 worth over $282,000. On average, Peter trades about 903 units every 32 days since 2003. As of 17 March 2014 Peter still owns at least 18,550 units of PPD Inc stock.
You can see the complete history of Peter Grunebaum stock trades at the bottom of the page.
Peter's mailing address filed with the SEC is 30TH FLOOR, 750 LEXINGTON AVENUE, NEW YORK, NY, 10022.
Over the last 22 years, insiders at PPD Inc have traded over $14,532,346,241 worth of PPD Inc stock and bought 130,455 units worth $3,520,800 . The most active insiders traders include Corporate Investors Viii, L..., Corporate Investors Vii, Lt..., and Group Management L.L.C.Carl.... On average, PPD Inc executives and independent directors trade stock every 53 days with the average trade being worth of $124,899,671. The most recent stock trade was executed by Corporate Investors Viii, L... on 8 December 2021, trading 132,841,266 units of PPD stock currently worth $6,309,960,135.
PPD is a leading global contract research organization providing comprehensive, integrated drug development, laboratory and lifecycle management services. Company's customers include pharmaceutical, biotechnology, medical device, academic and government organization s. With offices in 46 countries and more than 26,000 professionals worldwide, PPD applies innovative technologies, therapeutic expertise and a firm commitment to quality to help customers bend the cost and time curve of drug development and optimize value in delivering life-changing therapies to improve health.
PPD Inc executives and other stock owners filed with the SEC include: